Pharma Stocks
-
Is It Too Late To Reassess Amneal Pharmaceuticals (AMRX) After Its 65% One-Year Surge?
Some investors may be wondering if Amneal Pharmaceuticals at around US$12.80 is still reasonably priced after a strong run, or…
Read More » -
Crude shock temporary; pharma and EMS are the real bets: Abhay Agarwal
Abhay Agarwal, Founder and Fund Manager at Piper Serica, says the current spike in crude oil prices is sentiment-driven and…
Read More » -
AbbVie (ABBV) Stock Trades Up, Here Is Why
What Happened? Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 3.5% in the afternoon session after the company reported first-quarter results…
Read More » -
David Einhorn Likes This Pharma Stock
We just covered 15 Under-the-Radar Picks from David Einhorn That Are Quietly Dominating 2026 and Teva Pharmaceutical Industries Limited (NYSE:TEVA) ranks…
Read More » -
FTSE 100 Pharma Giants Defy Policy Pressures With Strong Start
Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos,…
Read More » -
Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed M…
Technical Trend Overview and Price Movement The stock of Piramal Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology…
Read More » -
Stronger Q1 Earnings And New CFO Might Change The Case For Investing In Incyte (INCY)
Incyte Corporation has reported first-quarter 2026 results showing sales of US$1,104.48 million, revenue of US$1,272.68 million, and net income of…
Read More » -
Is its pharma innovation edge strong enough to unlock new upside?
Orion Oyj focuses on proprietary pharmaceuticals with a strong Nordic base, but can its R&D pipeline drive sustained growth for…
Read More » -
Astellas Pharma (TSE:4503) Margin Surge To 13.6% Tests Bearish Earnings Narratives
Astellas Pharma (TSE:4503) has laid out its FY 2026 scorecard with second half revenue of ¥1.1t and basic EPS of…
Read More » -
Evaluating Indivior Pharmaceuticals (NasdaqGS:INDV) After New ASAM 2026 Data On Sublocade Effectiveness
Indivior Pharmaceuticals (INDV) drew fresh investor attention after presenting new real world data at the ASAM 2026 Annual Conference in…
Read More »